KARYOPHARM THERAPEUTICS INC.Karyopharm Therapeutics Inc. • August 31st, 2020 • Pharmaceutical preparations • Massachusetts
Company FiledAugust 31st, 2020 Industry JurisdictionSubject to your execution below, this letter hereby amends the offer letter, dated March 3, 2014, as amended and restated on January 23, 2015 and September 18, 2015, between you and Karyopharm Therapeutics Inc. (the “Company”), and provides for the following terms of employment. For the avoidance of doubt, nothing herein supersedes the Non-Disclosure and Inventions Assignment Agreement you previously executed with the Company, which remains in effect, unaltered, in all respects.
KARYOPHARM THERAPEUTICS INC.Karyopharm Therapeutics Inc. • November 9th, 2015 • Pharmaceutical preparations • Massachusetts
Company FiledNovember 9th, 2015 Industry JurisdictionSubject to your execution below, this letter hereby amends the offer letter, dated March 3, 2014, between you and Karyopharm Therapeutics Inc. (the “Company”), which was previously amended and restated on January 23, 2015, and provides for the following terms of employment:
KARYOPHARM THERAPEUTICS INC.Karyopharm Therapeutics Inc. • March 13th, 2015 • Pharmaceutical preparations • Massachusetts
Company FiledMarch 13th, 2015 Industry JurisdictionSubject to your execution below, this letter hereby amends the employment letter, dated March 2, 2014, between you and Karyopharm Therapeutics Inc. (the “Company”) and provides for the following terms of employment:
KARYOPHARM THERAPEUTICS INC.Karyopharm Therapeutics Inc. • January 23rd, 2015 • Pharmaceutical preparations • Massachusetts
Company FiledJanuary 23rd, 2015 Industry JurisdictionSubject to your execution below, this letter hereby amends the employment letter, dated July 2, 2014, between you and Karyopharm Therapeutics Inc. (the “Company”) and provides for the following terms of employment: